Washington HB 2613: Establishing safety and regulatory requirements for compounded medications.

Status: Public hearing in the House Committee on Health Care & Wellness at 8:00 AM. (as of 2026-01-30)

State: Washington · Session: 2025-2026 · Bill: HB 2613

Sponsors: Thai, Duerr, Hill, Ormsby, Parshley, Santos

View Washington HB 2613 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.